ClinicalTrials.govpublic full text
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies
neoplasms, hodgkin's disease, non-hodgkin's lymphoma, taxanes, multidrug resistance, mutant tubulin binding, hodgkin's or non-hodgkin's lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861070
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.